Cytokine storm and an anti-CD28 monoclonal antibody

被引：0
|
作者：
Corry, David B. [1 ]
Lewis, Dorothy E. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 24期
关键词：
TOXIC-SHOCK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2592 / 2592
页数：1
相关论文
共 50 条
  • [31] A Novel Anti-CD28 Domain Antibody Antagonist Shows a Favorable Pharmacokinetic, Pharmacodynamic and Safety Profile
    Shi, R.
    Honczarenko, M.
    Zhang, S.
    Fleener, C. A.
    Mora, J.
    Lee, S.
    Liu, X.
    Shevell, D. E.
    Yang, Z.
    Wang, H.
    Murthy, B.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [32] Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects
    Shi, Rong
    Honczarenko, Marek
    Zhang, Sean
    Fleener, Catherine
    Mora, Johanna
    Lee, Sun Ku
    Wang, Reena
    Liu, Xiaoni
    Shevell, Diane E.
    Yang, Zheng
    Wang, Haiqing
    Murthy, Bindu
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (02): : 161 - 172
  • [33] Anti-CD28 Antagonism Using a Monovalent Fab Antibody for the Prolongation of Human Skin Allograft Survival
    Zaitsu, M.
    Issa, F.
    Hester, J.
    Milward, K.
    Vanhove, B.
    Wood, K.
    TRANSPLANTATION, 2014, 98 : 26 - 26
  • [34] Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists
    Lühder, F
    Huang, Y
    Dennehy, KM
    Guntermann, C
    Müller, I
    Winkler, E
    Kerkau, T
    Ikemizu, S
    Davis, SJ
    Hanke, T
    Hünig, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (08): : 955 - 966
  • [35] HUMAN T-CELL ACTIVATION - DIFFERENTIAL RESPONSE TO ANTI-CD28 AS COMPARED TO ANTI-CD3 MONOCLONAL-ANTIBODIES
    BJORNDAHL, JM
    SUNG, SSJ
    HANSEN, JA
    FU, SM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (05) : 881 - 887
  • [36] COACTIVATION WITH ANTI-CD28 MONOCLONAL-ANTIBODY ENHANCES ANTI-CD3 MONOCLONAL ANTIBODY-INDUCED PROLIFERATION AND IL-2 SYNTHESIS IN T-CELLS FROM AUTOLOGOUS BONE-MARROW TRANSPLANT RECIPIENTS
    LUM, LG
    JOSHI, ID
    GALOFORO, SC
    ABELLA, E
    KARANES, C
    RATANATHARATHORN, V
    SCHULTZ, KR
    UBERTI, JP
    SENSENBRENNER, LL
    LEDBETTER, JA
    JUNE, CH
    BONE MARROW TRANSPLANTATION, 1993, 12 (06) : 565 - 571
  • [37] Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies
    Harada, M
    Okamoto, T
    Omoto, K
    Tamada, K
    Takenoyama, M
    Hirashima, C
    Ito, O
    Kimura, G
    Nomoto, K
    IMMUNOLOGY, 1996, 87 (03) : 447 - 453
  • [38] Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab' Antibody
    Poirier, N.
    Mary, C.
    Dilek, N.
    Hervouet, J.
    Minault, D.
    Blancho, G.
    Vanhove, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (10) : 2630 - 2640
  • [39] Anti-CD28 Antagonism Using a Monovalent Fab Antibody for the Prolongation of Human Skin Allograft Survival.
    Zaitsu, M.
    Issa, F.
    Hester, J.
    Milward, K.
    Vanhove, B.
    Wood, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 26 - 26
  • [40] Expansion of human CD4+T cells in vitro by bead-bound conventional anti-CD28 monoclonal antibodies
    Tarek, N.
    Hollmann, C.
    Wohlfarth, J.
    Schneider-Schaulies, J.
    Schilling, B.
    Kerkau, T.
    Beyersdorf, N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 275 - 275
12345